Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06287671 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Colorectal Omics and OfCS Proteoglycans

Study acronym: COCO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Dec 2028 to Dec 31, 2028
    • Study completion date: Dec 2032 to Dec 31, 2032
    • Start date changed from estimate of Aug 25, 2024 to Oct 8, 2024
    • Site details revised at 2 of 2 sites
  2. Start date: Apr 2024 to Aug 25, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study aims to test proteomics, metabolomics and proteoglycans as predictors of postoperative complications after colorectal surgery and as biomarkers of colorectal cancer. The main questions to answer are: * can these biomarkers predict anastomotic leakages * can these biomarkers predict recurrence after colorectal cancer * can these biomarkers be used as diagnostic tests for colorectal cancer * can these biomarkers be identified in the tumor Participants will undergo elective colorectal resection or stoma closure.
Trial Details
NCT Number NCT06287671
Lead Sponsor Claus Anders Bertelsen, PhD, MD
Collaborators: Viborg Regional Hospital
Conditions
(from sponsor)		 Colorectal Cancer, Diverticulitis, Colonic, Inflammatory Bowel Diseases, Stoma Colostomy
Related terms Colorectal Neoplasms, Diverticulitis, Colonic, Inflammatory Bowel Diseases
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov